- Home
- CPRX vs FA Comparison
CPRX vs FA Comparison
Compare CPRX & FA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPRX
- FA
- Stock Information
- Founded
- CPRX 2002
- FA 2003
- Country
- CPRX United States
- FA United States
- Employees
- CPRX N/A
- FA N/A
- Industry
- CPRX Biotechnology: Pharmaceutical Preparations
- FA Business Services
- Sector
- CPRX Health Care
- FA Consumer Discretionary
- Exchange
- CPRX Nasdaq
- FA Nasdaq
- Market Cap
- CPRX 2.5B
- FA 3.0B
- IPO Year
- CPRX 2006
- FA 2021
- Fundamental
- Price
- CPRX $22.78
- FA $18.60
- Analyst Decision
- CPRX Strong Buy
- FA Buy
- Analyst Count
- CPRX 7
- FA 8
- Target Price
- CPRX $32.86
- FA $20.80
- AVG Volume (30 Days)
- CPRX 1.4M
- FA 625.1K
- Earning Date
- CPRX 02-26-2025
- FA 02-27-2025
- Dividend Yield
- CPRX N/A
- FA N/A
- EPS Growth
- CPRX 114.68
- FA N/A
- EPS
- CPRX 1.18
- FA 0.03
- Revenue
- CPRX $460,482,000.00
- FA $755,643,000.00
- Revenue This Year
- CPRX $23.98
- FA $17.68
- Revenue Next Year
- CPRX $18.27
- FA $81.35
- P/E Ratio
- CPRX $19.33
- FA $654.57
- Revenue Growth
- CPRX 32.17
- FA N/A
- 52 Week Low
- CPRX $13.12
- FA $14.01
- 52 Week High
- CPRX $24.27
- FA $20.79
- Technical
- Relative Strength Index (RSI)
- CPRX 56.81
- FA 53.11
- Support Level
- CPRX $21.23
- FA $16.91
- Resistance Level
- CPRX $23.26
- FA $17.63
- Average True Range (ATR)
- CPRX 1.14
- FA 0.50
- MACD
- CPRX 0.20
- FA 0.03
- Stochastic Oscillator
- CPRX 74.85
- FA 74.12
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.
About FA First Advantage Corporation
First Advantage Corp is a provider of employment background screening and verification solutions. The company delivers services and insights that help its customers manage risk and hire talent. The Company has two reportable segments, Americas and International. The Americas segment provides technology solutions for screening, verifications, safety, and compliance in the United States, Canada, and Latin America markets. and the International segment provides technology solutions for screening, verifications, safety, and compliance outside of the Americas. The company derives its maximum revenue from America.